|
ROCK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1094237467878E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.9724001865693E-10 |
| Normal-vs-Stage2 |
3.62950000054596E-07 |
| Normal-vs-Stage3 |
2.28840280058762E-11 |
| Normal-vs-Stage4 |
1.48870027416592E-10 |
| Stage1-vs-Stage2 |
8.143200E-01 |
| Stage1-vs-Stage3 |
1.843800E-01 |
| Stage1-vs-Stage4 |
2.869600E-02 |
| Stage2-vs-Stage3 |
4.572600E-01 |
| Stage2-vs-Stage4 |
1.438430E-01 |
| Stage3-vs-Stage4 |
3.803600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.44582132324922E-12 |
| Normal-vs-AfricanAmerican |
3.465000E-03 |
| Normal-vs-Asian |
2.01369999996981E-06 |
| Caucasian-vs-AfricanAmerican |
2.028800E-01 |
| Caucasian-vs-Asian |
8.070400E-01 |
| AfricanAmerican-vs-Asian |
3.901200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40669698112106E-11 |
| Normal-vs-Female |
1.45859990752228E-11 |
| Male-vs-Female |
4.073600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.58270000333505E-08 |
| Normal-vs-Age(41-60Yrs) |
9.85989068169602E-13 |
| Normal-vs-Age(61-80Yrs) |
1.17929999099431E-10 |
| Normal-vs-Age(81-100Yrs) |
4.659400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.034780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.226200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.385000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.098200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.843800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.155200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.995700E-03 |
| Classical-VS-Follicular |
1.987720E-02 |
| Classical-VS-Other |
8.339900E-02 |
| Classical-VS-Normal |
1.54820001263545E-09 |
| Tall-VS-Follicular |
4.730800E-01 |
| Tall-VS-Other |
4.497800E-01 |
| Tall-VS-Normal |
6.90040025119742E-10 |
| Follicular-VS-Other |
3.142000E-01 |
| Follicular-VS-Normal |
6.26829699257314E-11 |
| Other-VS-Normal |
2.561100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.98117086572347E-12 |
| Normal-vs-N1 |
2.93799995443322E-09 |
| N0-vs-N1 |
4.420000E-01 |
|
|
